| 0 |
CENTRAL NERVOUS SYSTEM MASS |
29 |
0.3053 |
| 1 |
WALL MOTION SCORE INDEX ABNORMAL |
29 |
0.2636 |
| 2 |
AIRWAY REMODELLING |
29 |
0.2339 |
| 3 |
ATOPY |
29 |
0.1043 |
| 4 |
EOSINOPHILIC MYOCARDITIS |
29 |
0.0397 |
| 5 |
CARDIAC SEPTAL DEFECT |
27 |
0.0376 |
| 6 |
MICROANGIOPATHY |
29 |
0.0309 |
| 7 |
ACQUIRED CARDIAC SEPTAL DEFECT |
1 |
0.0169 |
| 8 |
BLOOD LEAD INCREASED |
1 |
0.0152 |
| 9 |
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS |
29 |
0.0142 |
| 10 |
EOSINOPHIL COUNT DECREASED |
29 |
0.0122 |
| 11 |
BLOOD IMMUNOGLOBULIN E INCREASED |
29 |
0.0120 |
| 12 |
RESPIRATORY SYMPTOM |
29 |
0.0102 |
| 13 |
EOSINOPHILIC PNEUMONIA |
29 |
0.0092 |
| 14 |
VENTRICULAR HYPOKINESIA |
29 |
0.0090 |
| 15 |
CHRONIC SINUSITIS |
29 |
0.0077 |
| 16 |
SOFT TISSUE NEOPLASM |
1 |
0.0076 |
| 17 |
NASAL POLYPS |
29 |
0.0059 |
| 18 |
EOSINOPHIL COUNT INCREASED |
29 |
0.0035 |
| 19 |
MUSCLE HYPERTROPHY |
1 |
0.0028 |
| 20 |
OBSTRUCTIVE AIRWAYS DISORDER |
29 |
0.0026 |
| 21 |
NODULE |
29 |
0.0022 |
| 22 |
LYMPHOPENIA |
29 |
0.0020 |
| 23 |
OBESITY |
29 |
0.0018 |
| 24 |
RESPIRATORY TRACT INFECTION |
29 |
0.0011 |
| 25 |
SELECTIVE EATING DISORDER |
1 |
0.0011 |
| 26 |
LACRIMATION INCREASED |
29 |
0.0010 |
| 27 |
VIRAL INFECTION |
29 |
0.0009 |
| 28 |
HAEMATURIA |
29 |
0.0008 |
| 29 |
RENAL DISORDER |
29 |
0.0006 |
| 30 |
PRODUCTIVE COUGH |
29 |
0.0006 |
| 31 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0006 |
| 32 |
PROSTATE CANCER |
29 |
0.0004 |
| 33 |
HAEMORRHAGE |
29 |
0.0003 |
| 34 |
ASTHMA |
29 |
0.0003 |
| 35 |
MEMORY IMPAIRMENT |
29 |
0.0002 |
| 36 |
SKIN NECROSIS |
1 |
0.0002 |
| 37 |
CONFUSIONAL STATE |
29 |
0.0002 |
| 38 |
REBOUND EFFECT |
2 |
0.0002 |
| 39 |
HYPERTENSION |
29 |
0.0001 |
| 40 |
GRAND MAL CONVULSION |
1 |
0.0001 |
| 41 |
CONDITION AGGRAVATED |
28 |
0.0001 |
| 42 |
PNEUMONIA |
29 |
0.0001 |
| 43 |
FISTULA |
1 |
0.0001 |
| 44 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 45 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 46 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 47 |
FEEDING DISORDER |
1 |
0.0000 |
| 48 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 49 |
PRODUCT USE IN UNAPPROVED INDICATION |
7 |
0.0000 |
| 50 |
ANGIOEDEMA |
1 |
0.0000 |
| 51 |
THERAPY CESSATION |
1 |
0.0000 |
| 52 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 53 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 54 |
THROMBOSIS |
1 |
0.0000 |
| 55 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 56 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 57 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 58 |
ADVERSE EVENT |
1 |
0.0000 |
| 59 |
CARDIAC DISORDER |
1 |
0.0000 |
| 60 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 61 |
SYNCOPE |
1 |
0.0000 |
| 62 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 63 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 64 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 65 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 66 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 67 |
PAIN |
2 |
0.0000 |
| 68 |
PYREXIA |
1 |
0.0000 |
| 69 |
OFF LABEL USE |
2 |
0.0000 |
| 70 |
VOMITING |
1 |
0.0000 |
| 71 |
NAUSEA |
1 |
0.0000 |